Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?

Rider LG, Miller FW.

Arthritis Rheum. 2010 Sep;62(9):2619-22. doi: 10.1002/art.27525. No abstract available.

2.

Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

Shrestha S, Wershil B, Sarwark JF, Niewold TB, Philipp T, Pachman LM.

Arthritis Rheum. 2010 Sep;62(9):2813-22. doi: 10.1002/art.27529.

3.

Dermatomyositis and type 1 interferons.

Greenberg SA.

Curr Rheumatol Rep. 2010 Jun;12(3):198-203. doi: 10.1007/s11926-010-0101-6. Review.

4.
5.

Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.

Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, Tüting T.

Clin Exp Dermatol. 2006 Jul;31(4):576-82.

PMID:
16716166
6.

Immunopathogenesis of juvenile dermatomyositis.

Khanna S, Reed AM.

Muscle Nerve. 2010 May;41(5):581-92. doi: 10.1002/mus.21669. Review.

PMID:
20405498
7.

Comment to "Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis".

Suárez-Calvet X, Gallardo E, Illa I.

J Neuroimmunol. 2016 Feb 15;291:125. doi: 10.1016/j.jneuroim.2015.12.008. Epub 2015 Dec 18. No abstract available.

PMID:
26723487
8.

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.

de Padilla CM, Reed AM.

Curr Opin Rheumatol. 2008 Nov;20(6):669-74. doi: 10.1097/BOR.0b013e3283157538. Review.

PMID:
18946326
9.

Pathogenesis of dermatomyositis: role of cytokines and interferon.

Kao L, Chung L, Fiorentino DF.

Curr Rheumatol Rep. 2011 Jun;13(3):225-32. doi: 10.1007/s11926-011-0166-x. Review.

PMID:
21318338
10.

Pathogenesis of myositis in children.

Griffin TA, Reed AM.

Curr Opin Rheumatol. 2007 Sep;19(5):487-91. Review.

PMID:
17762616
11.

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.

López de Padilla CM, Vallejo AN, McNallan KT, Vehe R, Smith SA, Dietz AB, Vuk-Pavlovic S, Reed AM.

Arthritis Rheum. 2007 May;56(5):1658-68.

12.

Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions.

Hargis AM, Haupt KH, Hegreberg GA, Prieur DJ, Moore MP.

Am J Pathol. 1984 Aug;116(2):234-44.

13.

Disparate antiviral responses in Molluscum contagiosum virus-induced skin lesions.

Swiecki M, Colonna M.

J Invest Dermatol. 2011 Feb;131(2):288-90. doi: 10.1038/jid.2010.368.

14.

Early immune events in the induction of allergic contact dermatitis.

Kaplan DH, Igyártó BZ, Gaspari AA.

Nat Rev Immunol. 2012 Jan 13;12(2):114-24. doi: 10.1038/nri3150. Review.

15.

Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions.

Gerlini G, Mariotti G, Bianchi B, Pimpinelli N.

J Invest Dermatol. 2006 Feb;126(2):507-9. No abstract available.

16.

A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.

Kim JM, Park SH, Kim HY, Kwok SK.

Int J Mol Sci. 2015 Jun 23;16(6):14158-70. doi: 10.3390/ijms160614158. Review.

17.

Immunological biomarkers in dermatomyositis.

Olazagasti JM, Niewold TB, Reed AM.

Curr Rheumatol Rep. 2015 Nov;17(11):68. doi: 10.1007/s11926-015-0543-y. Review.

PMID:
26404949
18.

Contribution of myeloid dendritic cells to type I interferon-induced cytokines and chemokines: comment on the article by Bilgic et al.

Maddur MS, Vani J, Lacroix-Desmazes S, Kaveri SV, Bayry J.

Arthritis Rheum. 2010 Jul;62(7):2181-2; author reply 2182. doi: 10.1002/art.27494. No abstract available.

19.

Antimicrobial peptides and self-DNA in autoimmune skin inflammation.

Gilliet M, Lande R.

Curr Opin Immunol. 2008 Aug;20(4):401-7. doi: 10.1016/j.coi.2008.06.008. Epub 2008 Jul 24. Review.

PMID:
18611439
20.

Dermatomyositis and polymyositis: clinical aspects.

Kagen LJ.

Clin Exp Rheumatol. 1984 Jul-Sep;2(3):271-7. Review. No abstract available.

PMID:
6397283

Supplemental Content

Support Center